Bladder Cancer - Results from #20

Photodynamic diagnosis-assisted en bloc transurethral resection of bladder tumor for non-muscle invasive bladder cancer: short-term oncological and functional outcomes. September 23, 2020

Evaluation of health care-associated infections following radical cystectomy. September 23, 2020

Development and Validation of a Model for Predicting Urethral Recurrence in Male Patients with Muscular Invasive Bladder Cancer After Radical Cystectomy Combined with Urinary Diversion. September 23, 2020

Expression and prognostic significance of the MMP family molecules in bladder cancer. September 23, 2020

Can we perform frozen section instead of repeat transurethral resection in bladder cancer? September 22, 2020

The Role of Imaging in Bladder Cancer Diagnosis and Staging. September 22, 2020

Impact of symptomatic recurrence on oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer. September 22, 2020

Massive intra-abdominal recurrence after robotic-assisted radical cystectomy: A case report and critical appraisal of literature. September 22, 2020

Durvalumab Alone and Durvalumab plus Tremelimumab Versus Chemotherapy in Previously Untreated Patients with Unresectable, Locally Advanced or Metastatic Urothelial Carcinoma (DANUBE): A Randomised, Open-Label, Multicentre, Phase 3 Trial September 21, 2020

Rates and Patterns of Recurrences, and Survival Outcomes after Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium. September 21, 2020

A deep learning network-assisted Bladder Tumor Recognition under Cystoscopy Based on Caffe Deep Learning Framework and EasyDL Platform. September 21, 2020

Enfortumab Vedotin-ejfv: A First-in-Class Anti-Nectin-4 Antibody-Drug Conjugate for the Management of Urothelial Carcinoma. September 21, 2020

Real-world systemic therapy utilization in Medicare patients with locally advanced or metastatic urothelial carcinoma diagnosed between 2008 and 2012. September 21, 2020

Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma September 18, 2020

Enfortumab Vedotin-Ejfv Significantly Improved Overall Survival in Phase 3 EV-301 Trial in Previously Treated Locally Advanced or Metastatic Urothelial Cancer September 18, 2020

Overview of the clinical use of erdafitinib as a treatment option for the metastatic urothelial carcinoma: where do we stand. September 18, 2020

Sequencing of PD-1/L1 Inhibitors and Carboplatin-Based Chemotherapy for Cisplatin-Ineligible Metastatic Urothelial Carcinoma. September 18, 2020

Urinary glycoproteomic profiling of non-muscle invasive and muscle invasive bladder carcinoma patients reveals distinct N-glycosylation pattern of CD44, MGAM, and GINM1. September 18, 2020

Current status and future perspectives of immunotherapy in bladder cancer treatment. September 18, 2020

Novel anticancer therapy in BCG unresponsive non-muscle-invasive bladder cancer. September 17, 2020

Page 2 of 364